RIOCIGUAT Drug Record
-
RIOCIGUAT chembl:CHEMBL2107834 Approved
Alternate Names:
BAY 63-2521 BAY-63-2521 RIOCIGUAT ADEMPAS METHYL N-(4,6-DIAMINO-2-{1-((2-FLUOROPHENYL)METHYL)-1H-PYRAZOLO(3,4-B)PYRIDIN-3-YL}PYRIMIDIN-5-YL)-N-METHYLCARBAMATE ADEMPAS® METHYL N-[4,6-DIAMINO-2-[1-[(2-FLUOROPHENYL)METHYL]-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]-5-PYRIMIDINYL]-N-METHYL-CARBAMINATE RIOCIGUATUM chembl:CHEMBL2107834 chemidplus:625115-55-1 drugbank:08931 pubchem.compound:11304743 rxcui:1439816 Drug Info:
FDA Approval not approved Drug Class small molecule Drug Indications antihypertensive agent
-
Interaction Types & Directionality:
activator (activating) positive modulator (activating) agonist (activating) stimulator (activating) Interaction Info:
Novel drug target Established target Trial Name riociguat, BAY-63-2521 Mechanism of Interaction Soluble guanylate cyclase positive allosteric modulator -
Interaction Types & Directionality:
activator (activating) positive modulator (activating) Interaction Info:
Trial Name riociguat, BAY-63-2521 Novel drug target Novel Target Mechanism of Interaction Soluble guanylate cyclase positive allosteric modulator -
Interaction Types & Directionality:
positive modulator (activating) Interaction Info:
Novel drug target Novel Target Trial Name riociguat, BAY-63-2521 Mechanism of Interaction Soluble guanylate cyclase positive allosteric modulator -
Interaction Types & Directionality:
activator (activating) positive modulator (activating) Interaction Info:
Mechanism of Interaction Soluble guanylate cyclase positive allosteric modulator Direct Interaction yes Novel drug target Novel Target
-
- Version: January-2014
Alternate Names:
Drug Info:
Drug Indications antihypertensive agent Drug Class small molecule FDA Approval not approved Publications:
-
Alternate Names:
D04UKC TTD Drug ID Drug Info:
Publications:
-
- Version: ChEMBL_27
Alternate Names:
Drug Info:
Publications:
-
- Version: chembl_23
Alternate Names:
Drug Info:
Publications: